SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (OTCBB:PURE) today reported financial results for the quarter ended October 31, 2006. Revenues for the fiscal quarter were $27,700 compared with revenues of $55,200 in the same quarter last year. The Company reported a net loss of $(867,300), or $(0.05) per share for the current quarter, compared with a loss of $(609,500), or $(0.04) per share in the prior year quarter.
